Latest cell therapy Stories
SAN DIEGO, Oct.
MONT-SAINT-GUIBERT, Belgium, October 23, 2014 /PRNewswire/ -- Cardio3 BioSciences (C3BS) (Euronext Brussels and Paris: CARD), a leader in the discovery and development
LONDON, Oct.20, 2014 /PRNewswire/ -- Report Details Stem cell developers and producers - discover companies' R&D and revenue prospects Who are the
Provides for Immediate Release of Initial Grant Funds MENLO PARK, Calif., Oct. 20, 2014 /PRNewswire/ -- Asterias Biotherapeutics, Inc.
RICHMOND, Calif., Oct. 16, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc.
- Preliminary study results show 27 of 30 pediatric and adult patients with relapsed/refractory (r/r) ALL (90%) experienced complete remissions with personalized cell therapy, CTL0191 EAST
Boston’s Adult Stem Cell Technology Center, LLC (ASCTC) was one of only eleven new companies selected to present their leading technologies and immediate commercial development goals in the
In a study published in September 2014 in STEM CELLS Translational Medicine journal, scientists found what they believe might be a better way to regrow bone tissue using magnetic nanoparticles
HypoThermosol® and CryoStor® Embedded in Internal Cell Therapy Candidates and Numerous Mutual Customer Regenerative Medicine Applications BOTHELL, Wash., Oct.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.